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Summary The marked female predominance in cases of idiopathic chronic cough and
its association with mild chronic lymphocytic airway inflammation suggests an
underlying autoimmune process. We set out to test the hypothesis that idiopathic
chronic cough is associated with other organ-specific autoimmune diseases in a case–
control study. Twenty-two patients with idiopathic chronic cough and 65 community-
matched controls for age and sex who responded to a self-administered questionnaire
were asked about the presence of autoimmune disease, other medical problems and
drug history. All subjects were invited to have a blood test for an autoimmune screen.
Thirteen out of 22 (59%) patients with idiopathic chronic cough and eight out of 65
(12%) age- and sex-matched controls reported organ-specific autoimmune disease
(odds ratio 8.8; 95% confidence interval 2.4–31.8, Po0:001). Organ-specific
autoantibodies were present in a significantly higher proportion of cases than
controls (40% vs. 13%; P ¼ 0:047). These findings suggest a relationship between
idiopathic chronic cough and organ-specific autoimmunity.
& 2003 Elsevier Ltd. All rights reserved.
Introduction
Cough is one of the commonest causes of presenta-
tion to general practice. At any one time, 20% of
the UK population have a troublesome cough and
sufferers consume 75 million doses of over-the-
counter anti-tussive medication annually.1 Most
cases are mild and self-limiting but a small
proportion have persistent troublesome cough and
require specialist review. Several series have shown
that a cause of persistent cough can be identified
relatively simply in 80–99% of cases with most
causes due to one or more of asthma, gastro-
oesophageal reflux and rhinitis with post-nasal
drip.2–4 However, in up to 20% of patients, the
cough remains unexplained even after extensive
investigation and treatment trials.3
Bronchoscopic studies have shown some evidence
of chronic airway inflammation with a mononuclear
cell infiltrate in the airway mucosa of patients with
idiopathic chronic cough.5 The nature of the airway
inflammation and the female predominance of
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patients with idiopathic chronic cough suggested to
us the possibility of an autoimmune process. Organ-
specific autoimmune diseases are commoner in
women and are associated with chronic lymphocy-
tic inflammation in the target organ. We have
tested the hypothesis that patients with idiopathic
chronic cough have a higher incidence of organ-
specific autoimmune disease in a case–control
study.
Methods
Cough diagnostic algorithm
Patients were recruited from consecutive patients
attending a specialised cough clinic run by Dr.
Pavord between 1998 and 1999 which receives
referrals from primary- and secondary-care largely
confined to a population of 970,000 within Leices-
tershire. Investigations were carried out according
to a standardised algorithm.2 The protocol for
investigation and treatment, and criteria for
accepting diagnosis were as previously de-
scribed.2,6 We defined idiopathic chronic cough as
a cough lasting 43 weeks in association with
normal clinical examination (including Ear Nose
Throat), normal chest X-ray and CT scan, normal
lung function tests, negative methacholine inhala-
tion test (provocative concentration: PC20
FEV1416mg/ml), normal peak expiratory flow
variability, no sputum eosinophilia and no patholo-
gical gastro-oesophageal reflux or evidence of
temporal association between cough and gastro-
oesophageal reflux on 24 h oesophageal pH mon-
itoring. Patients had normal macroscopic findings
on fibreoptic bronchoscopy and all had extensive
negative treatment trials including trials of inhaled
and systemic corticosteroids.2
Subjects
One hundred and fifty patients were seen in our
cough clinic (mean age 51 years [range 22–90],
females 66%) of which 25 (17%) fulfilled our criteria
for idiopathic chronic cough. The other primary
causes of cough were cough-variant asthma (15%),
gastro-oesophageal reflux (15%), rhinitis with post-
nasal drip (13%), eosinophilic bronchitis (17%),
post-viral cough (13%), chronic bronchitis and/or
bronchiectasis (8%) and angiotensin converting
enzyme inhibitor cough (2%). Identification of
controls was carried out using the method de-
scribed by Hubbard et al.7 Briefly, four controls
matched for age and sex were obtained for each
case that responded. These controls were drawn
from the list of the case patient’s general practi-
tioner and were selected randomly if more than
four suitable subjects were available; if four
controls of the same age were not listed with the
general practitioner the age matching was widened
to within 5 years.
Questionnaire and blood tests
On obtaining permission to enter each case and
their matched controls from their general practi-
tioner, a questionnaire was posted to each subject’s
home. The questionnaire asked specifically about
the presence of the following conditions: hy-
perthyroidism, hypothyroidism, diabetes, perni-
cious anaemia, Addison’s disease, alopecia,
vitiligo, coeliac disease, Crohn’s disease, ulcerative
colitis, premature menopause, autoimmune hepa-
titis, other medical problems and drug therapy. The
presence of self-reported organ-specific autoim-
mune diseases was validated (in cases) by review of
medical notes. The subjects were also invited to
have a blood test for an autoantibody screen which
included islet cell (in-house indirect immunofluor-
escence), adrenal (indirect immunofluorescence,
Biodiagnostics Ltd, Worcestershire, UK), parietal
(in-house indirect immunofluorescence), endomy-
sial8 (indirect immunofluorescence, Binding Site
Ltd, Birmingham, UK) and thyroid peroxidase
autoantibodies (fluorescent ELISA system, Pharma-
cia Diagnostics, Milton Keynes, UK).
Analyses
Matched case–control analysis of the incidence of
organ-specific autoimmune disease was done by
conditional logistic regression using the EGRET
computer statistical package.9 The effect of vari-
ables significantly associated with cough were
analysed in a multivariate model. The incidence
of organ-specific autoantibodies in each group were
compared by w2-test. The study had ethics approval
from the Leicestershire ethics committee.
Results
We obtained the general practitioner’s permission
to contact 25 idiopathic chronic cough patients and
88 controls. Twenty-two (88%) of the cases and 65
(74%) of the controls responded to the question-
naire. The distribution of age and sex among all
cases and controls, those that responded to the
questionnaire and those that had an autoantibody
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screen were similar and not statistically significant
(Table 1). The median duration of cough in cases
was 12 months (range 7–360 months). The response
to all questions asking about organ-specific auto-
immune disease is outlined in Table 2. Diseases
suggesting organ-specific autoimmunity were re-
ported by 13 cases (59.1%) and eight controls
(12.3%, Table 2). Matched case–control analysis
showed the difference to be highly significant (odds
ratio 8.8; 95% confidence interval 2.4–31.8,
Po0:001). A significantly higher proportion of the
cases had organ-specific autoantibodies present
than controls (40% vs. 13%; P ¼ 0:047; Table 2). In
the cases, positive thyroid autoantibody titres
ranged from 1:100 to 1:6400 (strong positive
titre41:100). In general, the presence of organ-
specific autoantibodies was consistent with self-
reported organ-specific autoimmune disease. Four
patients with explained chronic cough (n ¼ 125)
had organ-specific autoimmune disease or positive
auotantibodies (3.2%). Unexpectedly, non-steroidal
anti-inflammatory drug (NSAID) use for more than 2
months was reported more commonly by cases than
controls (10 (46%) vs. 8 (12%); odds ratio 5.6; 95%
confidence interval 2–18, Po0:01). Both associa-
tions (autoimmune disease and NSAID use) re-
mained significant and were essentially unchanged
when analysing using a multivariate model.
Discussion
We found a significantly higher prevalence of organ-
specific autoimmune disorders in patients with
idiopathic chronic cough. There was a similar
difference in the prevalence of organ-specific
autoantibodies between the two groups. These
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Table 1 Distribution of age and sex among all cases and controls identified, all respondents to the questionnaire
and those who had an autoantibody screen.
No. Men Women Overall mean(SD)
age (years)
No. (%) Mean(SD) age
(years)
No. (%) Mean(SD) age
(years)
Original sample
Cases 25 7(28) 54.2(5.4) 18(72) 55.4(3.0) 55.1(2.6)
Controls 88 21(24) 60.9(1.6) 67(76) 58.7(1.7) 59.2(1.3)
Respondents
Cases 22 5(23) 58.8(3.3) 17(77) 57.0(3.1) 57.5(2.5)
Controls 65 12(18) 63.3(2.1) 53(82) 55.7(1.9) 57.1(1.6)
Autoantibody
screen
Cases 15 3(20) 63.0(4.6) 12(80) 59.1(3.6) 59.9(3.0)
Controls 24 5(21) 51.6(9.6) 19(79) 52.8(2.9) 52.6(2.9)
No.¼ number; SD¼ standard deviation.
Table 2 Self-reported organ-specific autoimmune
disease and presence of organ-specific autoantibo-
dies in cases and controls.
Controls
(no.)
Cases
(no.)
n ¼ 65 n ¼ 22
Autoimmune disorder
Hypothyroidism 2 5
Hyperthyroidism 3 0
Diabetes mellitus type1 2 3
Pernicious anaemia 0 2
Celiac disease 1 1
Vitiligo and premature
menopause
0 1
Vitiligo and chronic
autoimmune hepatitis
0 1
Addison’s disease 0 0
Inflammatory bowel disease 0 0
Alopecia 0 0
Total 8 13nn
n ¼ 24 n ¼ 15
Autoantibodies
Thyroid peroxidase 0 4
Parietal cell 1 1
Endomysial 1 1
Islet cell 1 0
Adrenal 0 0
Total 3 6n
No.¼ number. nPo0:05; nnPo0:001:
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findings support our hypothesis that idiopathic
chronic cough is associated with the presence of
organ-specific autoimmune disease.
The controls represented a randomly selected
group and were not excluded if they had a cough,
smoked or had relevant occupational exposure.
This was to ensure that we were not selecting a
healthy group with an artificially lower prevalence
of potential causative factors such as organ-specific
autoimmune disease. As with all case–control
studies, our findings might be influenced by recall
bias in controls. However, the drug histories from
controls did not suggest under-reporting of auto-
immune disorders. Furthermore, the prevalence of
organ-specific autoimmune disease seen in the
control population was greater than expected from
general population surveys (3–8%)10,11 and from the
explained cough group (3.2%), suggesting that if
anything, there was over-reporting of autoimmune
disease in controls. Another possibility is that the
cases may have different health behaviour, increas-
ing the likelihood of seeking medical help and
receiving a diagnosis of organ-specific autoimmune
disease. However, the significantly higher preva-
lence of objective markers of organ-specific auto-
immunity in cases suggests this is not the sole
explanation for the association although we cannot
discount the possibility that the increased preva-
lence of NSAID use is due to this mechanism.
This is a small study, so we were not able to
compare the strength of association between
different organ-specific autoimmune disorders and
idiopathic chronic cough. Larger studies are re-
quired to investigate the possibility that particular
types of autoimmune diseases are associated with
cough. Autoimmune thyroid disease was the most
prevalent organ-specific autoimmune disorder in
cases with idiopathic chronic cough. On the basis of
our findings, we cannot exclude the possibility that
the association is exclusively due to a link between
autoimmune thyroid disease and idiopathic chronic
cough. Chronic cough has been reported as a
presenting feature of thyroiditis in two patients.12
In both, the cough improved following treatment of
the inflammatory thyroid disorder and was thought
to be due to a local irritative effect of the inflamed
thyroid. It is possible that local effects of a goitre
are responsible for cough in some patients. A more
general link between treated autoimmune thyroid
disease and increased respiratory morbidity is
supported by our recent findings of increased
prevalence of respiratory symptoms13 and unex-
plained fixed airflow obstruction14 in non-smoking
patients with treated autoimmune hypothyroidism.
The lungs and many of the organs involved in
organ-specific autoimmune disorders share com-
mon embryological origins as foregut derivatives
and it is possible that homing of activated T cells
into the pulmonary compartment as well as the
primary site of autoimmune inflammation may
cause airway wall inflammation and cough. Similar
mechanisms are thought to be responsible for the
lymphocytic airway inflammation seen in inflam-
matory bowel disease.15 Our recent description of a
case of chronic cough associated with broncho-
scopic evidence of lymphocytic broncho-alveolitis
which resolved following treatment of coeliac
disease16 and our finding of increased broncho-
alveolar lymphocyte counts in a cohort of patients
with idiopathic chronic cough provides some sup-
port for this mechanism.17 An alternative and
intriguing mechanism is that the cough might be
due to a hitherto unrecognised autoimmune bron-
chitis and that the association with other diseases
simply reflects the well-recognised association
between different organ-specific autoimmune dis-
eases. The failure of the cough to respond to
corticosteroids in the treatment trials our patients
were subjected to is not surprising since auto-
immune hypothyroidism, pernicious anaemia, in-
sulin-dependent diabetes mellitus and other organ-
specific autoimmune disorders differ from systemic
autoimmune diseases such as systemic lupus er-
ythematosis and rheumatoid arthritis in that they
do not typically respond to corticosteroids.11
Unexpectedly, we identified long-term NSAID use
in more cases than controls, independent of the
presence of autoimmune disease. This difference
was identified as a result of a post hoc analysis and
was not a primary outcome so we are cautious
about interpretation of these data. The association
is at first slightly surprising since prostaglandins are
thought to be endogenous tussive mediators18 and
NSAIDs have been shown to inhibit Angiotensin
Converting Enzyme Inhibitor chronic cough.19 How-
ever, the net effect of NSAIDs on airway prosta-
glandin production is far from clear and it is
possible that in certain circumstances these drugs
alter airway prostaglandin production so as to have
a protussive effect. An alternative possibility is that
NSAIDs cause airway inflammation, perhaps invol-
ving a similar mechanism to NSAID-induced coli-
tis.20 Finally, we cannot exclude the possibility that
patients used these drugs to ameliorate the
musculoskeletal complications of coughing.
In conclusion, we have identified a relationship
between idiopathic chronic cough and organ-
specific autoimmune disease. Further studies are
required to investigate this relationship in more
detail, determine whether it is associated with
airway inflammation, investigate the mechanisms
involved and test this hypothesis that other
ARTICLE IN PRESS
Idiopathic chronic cough 245
unexplained airway conditions are caused by
similar mechanisms.
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